31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
The IRS Office of Chief Counsel recently issued a Memorandum of Generic Legal Advice that makes clea...
Read More >
In early February, Senator Amy Klobuchar, new Chair of the Senate Judiciary Subcommittee on Antitrus...
Read More >
If January's minimum wage, tip, and overtime developments forecast what employers should expect thro...
Read More >
Statements to Individuals- The Internal Revenue Service (“IRS”) has extended the deadline for 2019...
Read More >
Because who wants a nice quiet December, right? Yesterday, the U.S. opened yet another trade war fro...
Read More >
On June 16, 2019, the Government of Canada issued an Order in Council, approving the proposed merger...
Read More >